Simvastatin and Radiculopathy - a phase IV clinical study of FDA data
Summary:
Radiculopathy is reported as a side effect among people who take Simvastatin (simvastatin), especially for people who are female, 60+ old, also take Aspirin, and have Crohn's disease.
The phase IV clinical study analyzes which people have Radiculopathy when taking Simvastatin. It is created by eHealthMe based on reports of 249,370 people who have side effects when taking Simvastatin from the FDA, and is updated regularly.
What is Simvastatin?
Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,970 Simvastatin users. Check the latest studies of Simvastatin.
What is Radiculopathy?
Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly) is found to be associated with 740 drugs and 608 conditions by eHealthMe. Check the latest studies of Radiculopathy.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
249,370 people reported to have side effects when taking Simvastatin.
Among them, 263 people (0.11%) have Radiculopathy.
Among these 263 people:
What is the gender of people who have Radiculopathy when taking Simvastatin? *
What is the age of people who have Radiculopathy when taking Simvastatin? *
What are other drugs people take besides Simvastatin? *
What are other side effects people have besides Radiculopathy? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Simvastatin and have Radiculopathy?
- Check whether Radiculopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Simvastatin:
- Simvastatin (256,970 reports)
Radiculopathy treatments and more:
- Radiculopathy (5,655 reports)
How severe was Radiculopathy and when was it recovered:
Expand to all the drugs that have ingredients of simvastatin:
- Radiculopathy and drugs with ingredients of simvastatin (401 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Simvastatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Radiculopathy:
- Radiculopathy (740 drugs)
Browse all the conditions that are associated with Radiculopathy:
- Radiculopathy (608 conditions)
Related publications that referenced our studies
- Foroughipour M, Farzadfard MT, Aghaee M, Ghabeli-Juibary A, Rezaietalab F, "Methamphetamine Related Radiculopathy: Case Series and Review of Literature", Asia Pacific Journal of Medical Toxicology, 2013 Jun .
- Foroughipour M, Farzadfard MT, Aghaee M, Ghabeli-Juibary A, Rezaietalab F, "Methamphetamine Related Radiculopathy: Case Series and Review of Literature", Asia Pacific Journal of Medical Toxicology, 2013 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on simvastatin (the active ingredients of Simvastatin) and Simvastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Climara vs. Estratab, side effect and effectiveness comparison - a second ago
- Leg Pain in Prilosec, how severe and when it was recovered? - 3 seconds ago
- Drug interactions of Cephalexin and Zegerid Otc - 4 seconds ago
- Vasotec and Clonidine drug interactions for women aged 20-29 - 6 seconds ago
- Red Blood Cell Count Decreased and drugs of ingredients of esomeprazole magnesium - 9 seconds ago
- Could Hctz cause Injection Site Swelling? - 18 seconds ago
- Drug interactions of Simvastatin and Lidocaine - 27 seconds ago
- Drug interactions of Alogliptin and Apixaban - 30 seconds ago
- Drug interactions of Levoleucovorin Calcium and Decadron - 35 seconds ago
- Could Propranolol Hydrochloride cause Disturbance In Attention? - 35 seconds ago